LYDERM
Google image searchProduct monograph
Active ingredient
fluocinonide, 0.05 %/W/W
DIN: 00716863
Dosage form(s): CREAM
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
Date: 06-DEC-2023
ATC:
- D07 — CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D07A — CORTICOSTEROIDS, PLAIN (ATC, ATC/DDD)
- D07AC — Corticosteroids, potent (group III) (ATC, ATC/DDD)
- D07AC08 — FLUOCINONIDE (ATC/DDD)
Reference brand drug: Lidex, Lyderm, Tiamol
Pharmaceutical standard: USP
